Published 7 hours ago • loading... • Updated 7 hours agoShow Less IconPrelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate ... Summary by Hastings TribuneCombination cohorts are part of Prelude’s Phase 1 trial evaluating PRT13722 in patients with HR+/HER2- breast cancer, on track to initiate enrollment in the fourth quarter of 2026Share menu1 Articles1 ArticlesAllLeftCenter1RightSearch IconSort IconHastings TribuneCenterFactualityOwnershipPrelude Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate ...Combination cohorts are part of Prelude’s Phase 1 trial evaluating PRT13722 in patients with HR+/HER2- breast cancer, on track to initiate enrollment in the fourth quarter of 20267 hours ago·Nebraska, United StatesRead Full ArticleThink freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribeBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsCoverage DetailsTotal News Sources1Leaning Left0Leaning Right0Center1Last Updated7 hours agoBias Distribution100% CenterBias Distribution Too Big Arrow IconToo Big Arrow IconCaret Up Icon100% of the sources are Center100% CenterC 100%Factuality Info IconTo view factuality data please Upgrade to PremiumOwnership Info IconTo view ownership data please Upgrade to VantageHastings Tribune broke the news in Nebraska, United States 7 hours ago on Tuesday, October 13, 2026.Too Big Arrow IconCaret Down IconSources are mostly out of (0)Similar News TopicsBreast Cancer Plus IconHastings, Nebraska Plus IconShow AllBlindspot Title And LogoStories disproportionately reported by the Left or the RightSee More BlindspotsSimilar News TopicsBreast Cancer Plus IconHastings, Nebraska Plus IconShow All